References
- Armand P, Kim HT, Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 2007;109:4586–4588.
- Sucak GT, Yegin ZA, Ozkurt ZN, et al. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation. Transplant Proc 2010;42:1841–1848.
- Lim ZY, Fiaccadori V, Gandhi S, et al. Impact of pre-transplant serum ferritin on outcomes of patients with myelodysplastic syndromes or secondary acute myeloid leukaemia receiving reduced intensity conditioning allogeneic haematopoietic stem cell transplantation. Leuk Res 2010;34:723–727.
- Alessandrino EP, Della Porta MG, Bacigalupo A, et al. Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study. Haematologica 2010;95:476–484.
- Artz AS, Wickrema A, Dinner S, et al. Pretreatment C-reactive protein is a predictor for outcomes after reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008;14:1209–1216.
- Tachibana T, Tanaka M, Yamazaki E, et al. Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant. Leuk Lymphoma 2013;54:1318–1320.
- Tachibana T, Takasaki H, Tanaka M, et al. Serum ferritin and disease status at transplantation predict the outcome of allo-SCT in patients with AML or myelodysplastic syndrome. Bone Marrow Transplant 2011;46:150–151.
- Tachibana T, Tanaka M, Numata A, et al. Pretransplant serum ferritin has a prognostic influence on allogeneic transplant regardless of disease risk. Leuk Lymphoma 2012;53:456–461.
- Armand P, Sainvil MM, Kim HT, et al. Does iron overload really matter in stem cell transplantation?Am J Hematol 2012;87:569–572.